Bank Of Montreal Silence Therapeutics PLC Transaction History
Bank Of Montreal
- $233 Billion
- Q3 2025
A detailed history of Bank Of Montreal transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Bank Of Montreal holds 153,782 shares of SLN stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153,782
Previous 145,812
5.47%
Holding current value
$1.06 Million
Previous $845,000
5.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SLN
# of Institutions
54Shares Held
20.6MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$20.8 Million1.76% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$20 Million0.59% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$14.9 Million1.24% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.84MShares$12.7 Million0.69% of portfolio
-
Morgan Stanley New York, NY1.21MShares$8.3 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $247M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...